Severe Obesity and Established Cardiovascular Disease TRIUMPH-3 (NCT05882045) evaluated 1,949 adults with Class II or Class III obesity (body mass index of at least 35 kg/m) and established cardiovascular disease, with or without type 2 diabetes
Statements Author contributions Both authors EM and SB have participated equally in article conception and design, acquisition of data, analysis and interpretation of data, drafting of manuscript, critical revision, and final approval of the version to be published
Tapering allows your body to gradually adjust to the absence of the medication, potentially minimizing the severity of the return of appetite and food noise
Obesity remains a major global health issue
Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity